Ò»¡¢Ñо¿Ëù¼ò½é
ÐÂÒ©´´ÖÆÓëÖÆÒ©¹¤³ÌÑо¿ËùÁ¥ÊôÓÚleyuÀÖÓ㣬Ö÷Òª´ÓÊÂÐÂÒ©Éè¼ÆºÍ¿ª·¢¡¢¹¤ÒÕ¸ïкÍÓÅ»¯¡¢ÖÆÒ©¹ý³ÌÉè¼ÆºÍ¿ØÖÆ¡¢Ò©ÎïмÁÐÍÑо¿¡¢Ò©Æ·É걨µÈÒ½Ò©ÁìÓòµÄÑо¿¹¤×÷¡£
Ñо¿ËùÏÂÉèËĸöÑз¢ÍŶӣ¬¼´£ºÒ©Î﹤ÒÕÑо¿Óë¹ý³Ì¿ª·¢ÍŶӡ¢Ò©ÎïÉè¼ÆÓëºÏ³ÉÑо¿ÍŶӡ¢ÖÐҩвúÆ·Ñз¢ÍŶӡ¢¿¹Ö×ÁöÒ©ÎïÓëÐÂÖÆ¼ÁÑо¿ÍŶӣ¬¾ßÓзḻµÄÒ½Ò©Ñо¿ºÍ¿ª·¢µÄ¾ÑéºÍÄÜÁ¦¡£Ä¿Ç°Ñо¿ËùÏÖÓнÌÖ°¹¤20ÈË£¬ÆäÖнÌÊÚ6ÈË¡¢¸±½ÌÊÚ5ÈË£¬¾ßÓв©Ê¿Ñ§Î»16ÈË¡£Í¬Ê±£¬ÓµÓÐÖÆÒ©»¯Ñ§¡¢ÖÆÒ©¹¤³Ì2¸ö¶þ¼¶Ñ§¿ÆË¶Ê¿µã¡£
Ëæ×ÅÒ½Ò©²úÒµµÄ¿ìËÙ·¢Õ¹£¬Ñо¿ËùÏȺó³Ðµ£¹ú¼Ò¼¶¡¢Ê¡¼¶¡¢µØÊм¶ºÍÆóÒµ¿ÆÑÐÏîÄ¿100¶àÏÒÑÈ¡µÃ¿ÆÑгɹû£¨ÎÄÕ¡¢Öø×÷ºÍרÀû£©200¶àÏî£¬ÔøÈÙ»ñ¹ú¼Ò¡¢Ê¡¡¢²¿¡¢Êм¶ºÍ¾Ö¼¶½±20ÓàÏî¡£ÅàÑøË¶Ê¿Ñо¿Éú100¶àÃû¡£´ËÍ⣬ӵÓÐ΢²¨»¯Ñ§ºÏ³ÉÒÇ¡¢Dionex U1 Ñ»·ÖƱ¸ÒºÏàÉ«Æ×ÒÇ¡¢SybylÒ©Îï·Ö×ÓÉè¼Æ¹¤×÷Õ¾¡¢×ÏÍâ¿É¼û½üºìÍâ·Ö¹â¹â¶ÈÒÇ¡¢¸µÁ¢Ò¶±ä»»ºìÍâ¹âÆ×ÒÇ¡¢ºË´Å¹²ÕñÒÇ¡¢LC-MSÁªÓÃÒÇ¡¢GC-MSÁªÓÃÒÇ¡¢Dionex Ultimate 3000¸ßЧҺÏàÉ«Æ×ÒǵÈÒ»Åú¿ÆÑÐÒÇÆ÷£¬ÄÜÓÐЧµØÂú×ã¿ÆÑеÄÓ²¼þÐèÇó¡£
ÐÂÒ©´´ÖÆÓëÖÆÒ©¹¤³ÌÑо¿ËùʼÖÕÒÔ¡°³ÏÐÅ¡¢´´Ð¡¢Çóʵ¡¢Ð×÷¡±µÄ¾«ÉñΪָÒý£¬¿ËÄѹ¥¼á¡¢ºÏ×÷¹²Ó®¡¢¼ÌÍù¿ªÀ´£¬Å¬Á¦ÎªÎÒ¹úÒ½Ò©²úÒµ·¢Õ¹ºÍÈËÀàÉúÃü½¡¿µ¹±Ï×Ò»·ÝÁ¦Á¿¡£
¶þ¡¢Ñо¿ÍŶÓ
1. Ò©Î﹤ÒÕÑо¿Óë¹ý³Ì¿ª·¢ÍŶÓ
ÒÔÂÌÉ«»¯Ñ§ºÍÂÌÉ«ÖÆÒ©Îª»ù´¡£¬¸ù¾ÝÒ©ÎïºÏ³ÉÉè¼Æ·½·¨½øÐÐзÏߺÍй¤ÒÕµÄ̽Ë÷Ñо¿¡£²ÉÓÃÕý½»Éè¼Æ»ò¾ùÔÈÉè¼Æ»ñÈ¡×îÓŵŤÒÕ²ÎÊý£¬½áºÏ·´Ó¦»úÀíºÍÎïÖʵÄÐÔÖʽøÐÐÖÆÒ©¹ý³Ì¿ØÖÆ£¬Ê¹µÃÖÆ±¸Ò©Îï·ûºÏÒ©Æ·µÄÖÊÁ¿±ê×¼ºÍÏàÓ¦µÄ¹ú¼Ò¹æ·¶ÒªÇ󣬴ӶøÂú×ãÒ©Îï·Ïß¿ª·¢Ëù×ñѵÄ×ȫ¡¢×úÍ×î¼ò½ÝµÄÖ¸µ¼ÔÔò¡£
ÍŶӸºÔðÈË£º
Ö÷Òª³ÉÔ±£ºÍõ¿¡¢Íò´º½Ü¡¢ÕÅÐãÀ¼¡¢¹ù¾Ù¡¢Áõ×Óά
2. Ò©ÎïÉè¼ÆÓëºÏ³ÉÑо¿ÍŶÓ
ÒÀ¾ÝÒ©Îï½á¹¹¡ª»îÐÔ£¨SAR£©µÄ¹ØÏµ£¬²ÉÓÃ×éºÏ»¯Ñ§¡¢¼ÆË㻯ѧ¡¢¼ÆËã»ú¸¨ÖúÒ©ÎïÉè¼ÆµÈ·½·¨£¬Éè¼Æ¾ßÓÐÌØ¶¨ÉúÎï»îÐÔµÄл¯Ñ§ÊµÌ壨NCEs£©£»Í¬Ê±£¬Ñо¿Ò©ÎïºÏ³ÉµÄ·´Ó¦ÀàÐͺͷ´Ó¦»úÀí£¬ÎªÒ©ÎïÖÆÔì¹ý³ÌÌṩÀíÂÛ»ù´¡¡£Í¬Ê±£¬½øÒ»²½½«Ñо¿ÖеÄз´Ó¦ºÍм¼ÊõÔËÓÃÏÖ´úÒ½Ò©Éú²ú¹ý³ÌÖ®ÖС£
ÍŶӸºÔðÈË£º¾ÞÐÞÁ·½ÌÊÚ
Ö÷Òª³ÉÔ±£º×£ºê¡¢Áõ»Û¡¢¹Å˫ϲ
3. ÖÐҩвúÆ·Ñз¢ÍŶÓ
ÒÔ´«Í³µÄÖÐÒ½Ò©ÀíÂÛΪ»ù´¡£¬½áºÏÏÖ´ú¶àѧ¿ÆµÄ֪ʶºÍ¼¼Êõ£¬½øÐÐÖÐÒ©µÄÌáÈ¡¡¢·ÖÀëºÍ´¿»¯¡£Í¬Ê±£¬ÓÃÖ²»¯·½·¨´Óµ¥Î¶ÖÐÒ©ÖзÖÀë²¢¼ø¶¨µ¥Ì壬Ëù·ÖÀëµ½µÄ³É·Ö½øÐÐϵͳ³õɸ£¬Ñ°ÕÒ×÷Óðе㣬Ã÷È·×÷ÓûúÖÆ£¬·¢ÏÖеĸßЧµÄÌìÈ»²úÎ²¢¶ÔÆä½øÐнṹÐÞÊΣ¬½ø¶ø·¢Õ¹ÎªÐÂÒ©¡£´ËÍ⣬Ҳ¿ª·¢Ò»Ð©ÒÔÖÐҩΪµ×ÎïµÄҩױƷºÍ±£½¡Æ·¡£
ÍŶӸºÔðÈË£º
Ö÷Òª³ÉÔ±£ºÐ¤ÑÞ»ª¡¢·½¼ÌµÂ¡¢È«´óÓÂ
4. ¿¹Ö×ÁöÒ©ÎïÓëÐÂÖÆ¼ÁÑо¿ÍŶÓ
´ÓÒ©ÎïÖÆ¼ÁµÄ½Ç¶È£¬ÒÔÌá¸ßÖÆ¼Á²úÆ·ÉúÎïÀûÓöȡ¢Îȶ¨ÐÔºÍÖÆ±¸ÊÕÂÊΪĿ±ê£¬¶ÔÖÆ¼Á¼¼ÊõÓëÒ©Óø߷Ö×Ó²ÄÁϽøÐÐʵÑéÑо¿£¬½ÒʾҩÓø߷Ö×Ó²ÄÁϵÄÎïÀíÐÔÖʺͻ¯Ñ§ÐÔÖÊ£¬¿ª·¢³öÄÜÂú×ã¿ØÊÍ»ºÊÍ¡¢°ÐÏò×÷Óá£Í¬Ê±£¬ÒÔÖ×Áö²úÉúµÄ²»Í¬»úÖÆ£¬À´Éè¼ÆºÍºÏ³É¿¹Ö×Áö»¯ºÏÎ²¢¶ÔÓÚ¿¹Ö×Áö»îÐÔ½øÐÐÑо¿£¬½ø¶ø·¢Õ¹³ÉΪÐÂÐ͵Ŀ¹Ö×ÁöÒ©Îï¡£
ÍŶӸºÔðÈË£º
Ö÷Òª³ÉÔ±£º¸ðÑàÀö¡¢·ë¾Õºì
Èý¡¢Ñо¿ÁìÓò
1. Ò©ÎïºÏ³É¹¤ÒÕÑо¿¼°¹ý³Ì¿ª·¢
½áºÏÐÂÒ©¼¼ÊõºÍÆóÒµÐèÇó£¬Ìṩ×î¼ÑµÄºÏ³É¹¤ÒÕ¡£°üÀ¨Ò©ÎïºÏ³É·ÏßµÄÉè¼Æ¡¢¹¤ÒÕÓÅ»¯¼°ÅÅ·ÅÎïÑ»·ÀûÓõȡ£
2. ÐÂÒ©¿ª·¢¼°³õ²½»îÐÔÑо¿
Ò©ÎïºÏ³É°üÀ¨Ò©Îï·Ö×ÓÉè¼Æ¡¢ºÏ³É¼°¹¹Ð§¹ØÏµÑо¿£»½áºÏÒ½Ò©ÐÐÒµµÄÑо¿ÈȵãÁìÓò£¬¿ª·¢ÐµĻ¯ºÏÎï»ò½øÐÐÒ©Îï½á¹¹¸ÄÔìÑо¿£¬²¢½øÐгõ²½µÄ»îÐÔÑо¿£¬ÖصãÃé×¼¿¹Ö×ÁöÒ©ÎïµÄ¿ª·¢¼°»îÐÔÑо¿¡£
3. ÌìÈ»²úÎïµÄÌáÈ¡¼°»îÐÔÑо¿
ÌìÈ»²úÎïµÄÌáÈ¡·ÖÀë¼°³õ²½µÄ»îÐÔɸѡ£¬Ò½Ò©±£½¡Æ·¼°¹¦ÄÜÐÔ»¯×±Æ·µÄÅä·½Ñо¿¡¢¼ìÑé±ê×¼Ñо¿µÈ¡£
4. Ò½Ò©¸ß·Ö×Ó²ÄÁÏÓëÒ©ÎïÖÆ¼Á¼¼Êõ
´ÓÒ©ÎïÖÆ¼ÁµÄ½Ç¶È£¬ÒÔÌá¸ßÖÆ¼Á²úÆ·ÉúÎïÀûÓöȡ¢Îȶ¨ÐÔºÍÖÆ±¸ÊÕÂÊΪĿ±ê£¬¶ÔÖÆ¼Á¼¼ÊõÓëÒ©Óø߷Ö×Ó²ÄÁϽøÐÐʵÑéÑо¿£¬½ÒʾҩÓø߷Ö×Ó²ÄÁϵÄÎïÀíÐÔÖʺͻ¯Ñ§ÐÔÖÊ£¬¿ª·¢³öÄÜÂú×ã¿ØÊÍ»ºÊÍ¡¢°ÐÏò×÷Óã¬ÒÔ¼°Ìá¸ßÉúÎïÀûÓöȡ¢Îȶ¨ÐÔºÍÑÚ¸ÇÒ©ÎïµÄ²»Á¼ÐáζµÈÒªÇóµÄÖÆ¼Á²ÄÁϺÍй¤ÒÕ£¬ÎªÖƼÁ¹¤³Ì»¯µÄÉ豸ÓëÉèÊ©Éè¼Æ¡¢°²×°ºÍÔËÐÐÌṩÀíÂÛ»ù´¡Óëʵ¼ùÒÀ¾Ý¡£
ËÄ¡¢Ñо¿³É¹û
1. ´ú±íÐÔ¿ÆÑÐÂÛÎÄ
(1) Yuki Akiyoshi, Shogo Furutani, Xiu-Lian Ju, Kazuhiko Matsuda, Yoshihisa Ozoe, Electrophysiological evidence for 4-isobutyl-3-isopropylbicyclophosphorothionate as a selective blocker of insect GABA-gated chloride channels, Bioorg. & Med. Chem. Lett., 2013, 23:3373-3376
(2) Jin Cheng, Xiu-Lian Ju*, Homology modeling and atomic level binding study of GABAA receptor with novel enaminone amides, Eur. J. Med. Chem. 2010, 45:3595-3600
(3) Xiu-Lian Ju, Sayaka Fusazaki, Hiroyuki Hishinuma, Xiaomu Qiao, Izumi Ikeda,Yoshihisa Ozoe, Synthesis and structure¨Cactivity relationshipanalysis of bicyclophosphorothionate blockers with selectivity for housefly ¦Ã ¨Caminobutyric acid receptor channels, Pest Manag. Sci. 2010, 66:1002-1010
(4) Gen-Yan Liu, Xiu-Lian Ju*, Jin Cheng and Zhi-Qiang Liu. 3D-QSAR studies of insecticidal anthranilic diamides as ryanodine receptor activators using CoMFA, CoMSIA and DISCOtech. Chemosphere 2010, 78:300-306
(5) Jie Pan, Gen-Yan Liu, Jin Cheng, Xin-Jie Chen and Xiu-Lian Ju*. CoMFA and molecular docking studies of benzoxazoles and benzothiazoles as CYP450
£¨6£©Íõ¿, ·ûÕ×ÁÖ, ¼ÖÌÎ, ÕÅÐãÀ¼, ¸ðÑàÀö, ¾ÞÐÞÁ·. ×óɳ¶¡°·´¼ÑÎËáÑεÄÖÆ±¸¼°ÆäS-¶ÔÓ³ÌåµÄÍâÏûÐý»¯. ÖйúҩѧÔÓÖ¾, 2007, 42£¨21£©, 145-146.
£¨7£©Kai Wang, Chun-Ting Poon, Wai-Kwok Wong, Wai-Yeung Wong, Daniel W. J. Kwong, Heng Zhang, Zao-Ying Li. Synthesis, Characterization, Singlet Oxygen Photogeneration, DNA Photocleavage and Two-Photon Absorption Properties of Some 4-Cyanophenylporphyrins. European Journal of Inorganic Chemistry, 2009, 922-928.
£¨8£©Kai Wang, Chun T. Poon, Chun Y. Choi, Wai K. Wong, Daniel W. J. Kwong, Fa Q. Yu, Heng Zhang, Zao Y. Li. Synthesis, Circular Dichroism, DNA Cleavage and Singlet Oxygen Photogeneration of 4-Amidinophenyl Porphyrins. Journal of Porphyrins and Phthalocyanines, 2012, 16 (1), 85-92.
£¨9£©Íõ¿, ÁÖЦ, ÍòÐÒ, ¼ÖÌÎ, ÕÅÐãÀ¼, ÕÅçñ, ¾ÞÐÞÁ·. îÉ-·ÆÂÞ߸߲߸µÄºÏ³É¼°ÆäÓëDNAÏ໥×÷ÓÃÑо¿. ¸ßµÈѧУ»¯Ñ§Ñ§±¨, 2012, 33(12), 2663-2669.
£¨10£©Íõ¿£¬ÕÅÐÛ£¬½ðç÷£¬ÕÅÐãÀ¼£¬ÕÅçñ. À¿Æõ£°·µÄºÏ³É. ÖйúÒ½Ò©¹¤ÒµÔÓÖ¾, 2014, 45 (7), 603-605.
(11) Shuang-Xi Gu*, Yuan-Yuan Zhu, Fen-Er Chen*, Erik De Clercq, Jan Balzarini, Christophe Pannecouque. Structural modification of diarylpyrimidine derivatives as HIV-1 reverse transcriptase inhibitors. Medicinal Chemistry Research, 2014, accepted, DOI: 10.1007/s00044-014-1119-5.
(12) Shuang-Xi Gu, Jia-Wen Du, Xiu-Lian Ju*, Qing-Ping Chen, A Scalable One-Pot Process for the Synthesis of Florfenicol Phosphodiester. Organic Process Research & Development, 2014, 18 (4), 552-554.
(13) Shuang-Xi Gu, Zhi-Ming Li, Xiao-Dong. Ma, Shi-Qiong Yang, Qiu-Qin He, Fen-Er Chen*, Erik De Clercq, Jan Balzarini, Christophe Pannecouque, Chiral resolution, absolute configuration assignment and biological activity of racemic diarylpyrimidine CH(OH)-DAPY as potent nonnucleoside HIV-1 reverse transcriptase inhibitors. European Journal of Medicinal Chemistry,2012, 53, 229-234.
(14) ¹Å˫ϲ*£¬ÀîæÃæÃ£¬ÖìÔ°Ô°. ÑÎËáÎÄÀ·¨ÐÁºÏ³É·Ïßͼ½â. ÖйúÒ½Ò©¹¤ÒµÔÓÖ¾, 2014, 45(2), 187-189.
(15) ¹Å˫ϲ*£¬¶ÎæÃ£¬ÇǺ㣬¾ÞÐÞÁ·. ÂÈɳ̹µÄºÏ³É¹¤ÒÕÑо¿½øÕ¹. ¾«Ï¸»¯¹¤, 2014, 31(3), 272-282.
(16) Íõ¼Î£¬ÕÅÐãÀ¼*£¬ÕÅçñ£¬Íõ¿£¬ÑîÒպ磬ÑîÔ£¶°.·ûºÏ2010°æGMPÒªÇóµÄÎÞ¾ú·ÛÕë³µ¼ä¹¤ÒÕÉè¼Æ.Ò½Ò©¹¤³ÌÉè¼Æ, 2013£¬24(2) £º8¡«11.
(17) Zhang Xiulan, Zhang Heng,Yang Yihong, Wang Kai, Wang Jia. Designing facilities for aseptic filling. Cleanroom Technology, 2013,3:20-22.
(18) ÕÅÐãÀ¼£¬ÑîÒպ磬ÕÅçñ£¬»Æ½¿½¿£¬ÁÖ³¿.¿¹ÒÖÓôÒ©àçÝÁÆÕÍ¡ÄÆµÄºÏ³Éй¤ÒÕ. ¹ã¶«»¯¹¤, 2013£¬40(2)£º9¡«10.
(19) XIULAN ZHANG, HENG ZHANG, YIHONG YANG, ZHENYU CHEN. self-assembling behavior and inhibition effect of dodecanethiol self-assembled monolayers on copper surface. Surface Review and Letters. 2013,76,173-177.
(20) ÕÅÐãÀ¼£¬Íõ¼Î£¬ÑîÔ£¶°£¬ÕÅçñ£¬Íõ¿. ¾²ÂöµÎ×¢ÓÃÎÞ¾ú¶³¸É·ÛÕë³µ¼ä¹¤ÒÕÉè¼Æ. ÖйúÒ©Ê£¬2012£¬26(12):1402-1405.
£¨21£©×£ºê, ÌÆÖ¾ìÍ, ÈÙ¿·å. ɱ¾ú¼ÁË®Ñîõ£Õý¶¡°·µÄºÏ³É¼°±íÕ÷. ɽ¶«»¯¹¤, 2011, 40(4), 20-22.
£¨22£©×£ºê, ¸ßϼ, Å˾æÂ. ×¢ÉäÓÃÒøÐÓÄÚõ¥BÔڱȸñÈ®ÌåÄÚµÄÒ©´ú¶¯Á¦Ñ§Ñо¿. ɽ¶«»¯¹¤, 2011, 40(2), 11-16.
£¨23£©×£ºê, ÅË־Ȩ. ‡fàËáµÄºÏ³É¹¤ÒÕÑо¿. »¯Ñ§¹¤³ÌÓë×°±¸, 2010, 11, 6-10.
£¨24£©×£ºê, ÅË־Ȩ. Í×ÇúÖéÀûµÄºÏ³É¹¤ÒÕÑо¿. »¯Ñ§¹¤³ÌÓë×°±¸, 2010, 10, 3-8.
£¨25£©LI Li, CHEN Keli, XU Jiacheng. Inhibition on lipoxygenase of the flavonoids from Selaginella labordei. The 6th Joint China-Japan Chemical Engineering Symposium (CJCES-6). Wuhan,China,20th-24th June, 2011
£¨26£©LI Li, CHEN Ke-li, XU Jia-cheng, LEI Xiang. Inhibition action on Xanthine Oxidase by biflavonoids from Selaginella labordei. The 3rd International Conference on Bioinformatics and Biomedical Engineering (iCBBE 2009).
£¨27£©Liu ZW, Liu ZM, Zhang XL, Xue PP, Zhang H*. RY10-4 suppressed metastasis of MDA-MB-231 by stabilizing ECM and E-cadherin. Biomedicine & Pharmacotherapy, 2014, 68, 439-445.
£¨28£©ÖÜÃεû, ÖܼÓÓ¢, ÑîÒÕºç, ÕÅçñ*, ÖÓÎä*. ÖØÒªçÞÌåÒ½Ò©ÖмäÌ壨£²£²£Å£©-¶¹çÞ-£±,£´,22-ÈýÏ©-£³-ͪµÄºÏ³É¹¤ÒոĽø. ¾üÊÂҽѧ, 2014,38(6),471-473.
(29) Shuang Cao ,Xin-Bo Zhou,Heng zhang,Song Li,Wu Zhong*. Novel cross-link based on zwitterion structureSynthesis,structure and druggability studies.European Journal of Medicinal Chemistr Chemistry, 2013,68,89-95.
(30) ÐíæÂ£¬ÕÅçñ*£¬ÑîÒպ磬²Üˬ£¬ÖÓÎä. ÒÒ±ûÎôÂ޵ĺϳɹ¤ÒÕÑо¿[J]. ¾üÊÂҽѧ, 2013, 37(6), 403-405.
(31) »Æ½¿½¿£¬ÕÅçñ*£¬ÑîÒպ磬ÁÖ³¿. 4,6-¶þÂÈ-5-(2-¼×Ñõ»ù-±½Ñõ»ù)-2,
(32) Ju Guo, Wenfang Dong, Zheng Yan, Nan Wang, Zhanzhu Liu. Synthesis and cytotoxicity of 3-arylacrylic amide derivatives of the simplified saframycin-ecteinascidin skeleton prepared from L-dopa.European Journal of Medicinal Chemistry, 2013, 62, 670--676.
£¨33£©Xiang Lei, Guo Xiaofang, Li Xinxiong, Hu Xuelei*. Temperature-dependent Polymorphism in Co(II) Coordination Polymers from 5-Nitroisophthalate and 1,3- Bis(4-pyridyl)propane. Chinese Journal of Structural Chemistry, 2013, 32(11): 1680.
£¨34£©Shu Qixia, Sun Guoyuan, Wang Xiaobo, Hu Xuelei*. Hydrothermal synthesis and crystal structure of a novel rare-earth tungsten phosphate supramolecular compound. Inorganic Chemistry Communications, 2012, 21, 47.
£¨35£©Li Liuyi, Zhu Lei, Chen Dagui, Hu Xuelei*, Wang Ruihu*. Use of Acylhydrazine- and Acylhydrazone-Type Ligands to Promote CuI©\Catalyzed C-N Cross-Coupling Reactions of Aryl Bromides with N-Heterocycles. European Journal of Organic Chemistry, 2011, 2011(14): 2692.
£¨36£© WU Qi-Feng, LI Wen, ZHU Zhi-Meng, WANG Xuan, HU Xue-Lei*, PAN Zhi-Quan. Characterization and Luminescence Properties of a New Europium (III) Complex with a Macrocyclic Ligand£¬Journal of Wuhan University of Technology-Mater. Sci. Ed., 2010, 25(6), 987-990.
£¨37£©ÍõÒøÆ½£¬ÎâÆð·å£¬ÏÄÓê¼Ñ£¬ºúѧÀ×*, ÅË־Ȩ. Ho(III)Ï£·ò¼î´ó»·ÅäºÏÎïµÄºÏ³É¡¢¾§Ìå½á¹¹¼°Æä¶ÔDNAµÄÇиî»îÐÔÑо¿. ¸ßµÈѧУ»¯Ñ§Ñ§±¨£¬2010, 31(12)£¬2344-2348.
£¨38£©Yanli Ge, Xiaocheng Weng, Tian Tian, Fei Ding, Rong Huang, Libo Yuan, Jun Wu, Tianlu Wang, Pu Guo, Xiang Zhou*. A mitochondria-targeted zinc(II) phthalocyanine for photodynamic therapy. RSC Advances, 2013, 3, 12839-12846.
£¨39£©¸ðÑàÀö£¬Õűø£¬³Ì誣¬½ª·ï³¬£¬¾ÞÐÞÁ·*. ·¼»ù»Ç°·Àà¦Ã-·ÖÃÚøÒÖÖÆ¼ÁµÄÈýά¶¨Á¿¹¹Ð§¹ØÏµÑо¿£¬¼ÆËã»úÓëÓ¦Óû¯Ñ§£¬2010£¬27(4): 475-479.
£¨40£©Ju-Hong Feng, Wei Chen, Yu Zhao, Xiu-Lian Ju, Anti-Tumor Activity of Oleanolic, Ursolic and Glycyrrhetinic Acid. The Open Natural Products Journal, 2009, 2, 43-47.
£¨41£©·ë¾Õºì£¬¶¡ÌΣ¬ÈÙϼ£¬¾ÞÐÞÁ·. 1,3,5-ÈýàºÀàÑÜÉúÎïµÄºÏ³É¼°Æäɱ¾ú»îÐÔ. leyuÀÖÓãѧ±¨(×ÔÈ»¿ÆÑ§°æ), 2013, 35(4): 35-37.
£¨42£©·ë¾Õºì£¬ÈÙϼ£¬ÃÏÎõ£¬¾ÞÐÞÁ·. 6-¼×Ñõ»ù-2-±½²¢¶ñßòͪºÏ³É¹¤ÒÕ. leyuÀÖÓãѧ±¨£¨×ÔÈ»¿ÆÑ§°æ£©£¬2011£¬33(12): 18-19.
£¨43£©·ë¾Õºì£¬¹¨ê¿£¬ÈÙϼ£¬¾ÞÐÞÁ·. ÐÂÐÍN-±½¼×õ£»ùÏõ»ùëÒÀ໯ºÏÎïµÄºÏ³É¼°É±¾ú»îÐÔ. leyuÀÖÓãѧ±¨£¨×ÔÈ»¿ÆÑ§°æ£©£¬2013£¬35(12): 44-47.
£¨44£©·ë¾Õºì£¬ÐÜÀÙ£¬ÈÎС·Æ£¬ÂíÖÒ»ª. ¹è»ù¸ºÔØÈ«·ú¶¡»ù»Çõ£Ñǰ·´ß»¯ÏËÎ¬ËØµÄË®½â. leyuÀÖÓãѧ±¨£¨×ÔÈ»¿ÆÑ§°æ£©£¬2014£¬36(5): 9-14.
2. ´ú±íÐÔ¿ÆÑÐÏîÄ¿
(1) Âȼװ·Á×µÄÑо¿¿ª·¢(2004BA
(2) Ë«»·Áò»¯Á×Ëáõ¥À໯ºÏÎïµÄºÏ³É¼°¶Ô²¸È鶯ÎïÓëÀ¥³æGABAÊÜÌåÑ¡Ôñ»îÐÔµÄÑо¿(20572084),¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð,2005Äê,ÏîÄ¿¸ºÔðÈË--¾ÞÐÞÁ·¡£
(3) »·ÑõßøµÄÑо¿¿ª·¢£¬ÆóÒµºáÏò£¨Î人ÖÐöλ¯¹¤£©£¬2008Ä꣬ÏîÄ¿¸ºÔðÈË--¾ÞÐÞÁ·¡£
(4) B2 µÄÁ×Ëáõ¥µ¥ÄÆÑι¤Òµ»¯£¬ÆóÒµºáÏò£¨ºþ±±¹ã¼ÃÒ©Òµ£©£¬2009Ä꣬ÏîÄ¿¸ºÔðÈË--¾ÞÐÞÁ·¡£
(5) VB6ÐÂÉú²ú¹¤ÒÕÑо¿£¬ÆóÒµºáÏò£¨ºþ±±»ÝÉúÒ©Òµ¹É·ÝÓÐÏÞ¹«Ë¾£©£¬2013Ä꣬ÏîÄ¿¸ºÔðÈË--¾ÞÐÞÁ·¡£
£¨6£©Á½ÐÔ£¨Ç×Ë®/ÊèË®£©ß²ßø»¯ºÏÎïµÄºÏ³É¼°ÆäÓëDNA¡¢Ö×Áöϸ°ûµÄ¹â¶¯Á¦»îÐÔÑо¿£¨20902071£©, ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð, 2009Äê, ÏîÄ¿¸ºÔðÈË--Íõ¿¡£
£¨7£©¿¹°©Ò½Ò©ÖмäÌåõ£»¯±í¹í¾Ê¶¾ËصÄÑз¢, ÉϺ£ÇàÆÖÇø²úѧÑкÏ×÷·¢Õ¹×ʽðÏîÄ¿£¨qcxyhzfzzj0012£©, 2011Äê, ÏîÄ¿¸ºÔðÈË--Íõ¿¡£
£¨8£©Ë¿°±ËáϵÁвúÆ·Éî¶È¿ª·¢¼°¼¼ÊõÖ§³Ö, ÆóÒµºáÏò, 2012Äê, ÏîÄ¿¸ºÔðÈË--Íõ¿¡£
£¨9£©Ò½Ò©¼°ÖмäÌå²úÆ·¿ª·¢¼°¼¼ÊõÖ§³Ö£¬ÆóÒµºáÏò£¬2013Ä꣬ÏîÄ¿¸ºÔðÈË--Íõ¿¡£
£¨10£©¹²éîÌåÏµË«ß²ßø»¯ºÏÎïµÄºÏ³É¼°ÆäÓëDNA¹â¶¯Á¦»îÐÔÑо¿. ºþ±±Ê¡½ÌÓýÌü¿ÆÑ§Ñо¿¼Æ»®ÖصãÏîÄ¿(D20141506), 2014, ÏîÄ¿¸ºÔðÈË--Íõ¿¡£
£¨11£©HIV-1Äæ×ªÂ¼Ã¸/ÕûºÏÃ¸Ë«ÖØÒÖÖÆ¼ÁDKA-DAPYsµÄ·Ö×ÓÉè¼Æ¡¢ºÏ³É¼°¿¹HIV»îÐÔÑо¿£¨21402148£©£¬¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð£¬2014Ä꣬ÏîÄ¿¸ºÔðÈË--¹Å˫ϲ¡£
£¨12£©Ë«°Ðµã¿¹HIVÒ©ÎïµÄÉè¼Æ¡¢ºÏ³ÉÓëÉúÎï»îÐÔÑо¿£¨Q20141505£©£¬ºþ±±Ê¡½ÌÓýÌü¿ÆÑ§¼¼ÊõÑо¿¼Æ»®ÇàÄêÈ˲ÅÏîÄ¿£¬2014Ä꣬ÏîÄ¿¸ºÔðÈË--¹Å˫ϲ¡£
£¨13£©ºþ±±Ê¡¸ßµÈѧУÇàÄê½ÌʦÉîÈëÆóÒµÐж¯¼Æ»®£¨XDXD2014154£©£¬2014Ä꣬ÏîÄ¿¸ºÔðÈË--¹Å˫ϲ¡£
£¨14£©Ì¼ÇàùϩÀ࿹ÉúËØ1¦Â-¼×»ù̼Çàùϩ˫»·Ä¸ºËµÄºÏ³É£¬ºþ±±Ê¡½ÌÓýÌü¿ÆÑ§¼¼ÊõÑо¿¼Æ»®ÇàÄêÈ˲ÅÏîÄ¿£¨20141510£©£¬2013Ä꣬ÏîÄ¿¸ºÔðÈË--ÕÅÐãÀ¼¡£
£¨15£©3-(1-ßß़׻ù)±½Ñõ±û°·µÄºÏ³É¹¤ÒÕÑо¿¼°ÖÐÊÔ·Å´ó³õ²½Ñо¿£¬ºþ±±¿¨ÍÍÒ±½ðÉ豸¿Æ¼¼ÓÐÏÞ¹«Ë¾£¬2013Ä꣬ÏîÄ¿¸ºÔðÈË--ÕÅÐãÀ¼¡£
£¨16£©¿¹¸ßѪѹÐÂÒ©¶¡ËáÂÈάµØÆ½µÄºÏ³ÉÑо¿£¬leyuÀÖÓãÇàÄê¿ÆÑ§»ù½ðÏîÄ¿£¨Q201203£©£¬2012Ä꣬ÏîÄ¿¸ºÔðÈË--ÕÅÐãÀ¼¡£
£¨17£©´¿ÌìÈ»¸ßЧ»·±£Ïû¶¾¼ÁµÄÑÐÖÆ¿ª·¢£¬ÆóÒµºáÏò£¬2009Ä꣬ÏîÄ¿¸ºÔðÈË--ÀèÀò¡£
£¨18£©ÖÐÒ©ÃÀ°×Äý½º¼ÁµÄÑо¿£¬ÆóÒµºáÏò£¬2009Ä꣬ÏîÄ¿¸ºÔðÈË--ÀèÀò¡£
£¨19£©½ÌÓý²¿ÈËÎÄÉç»á¿ÆÑ§Ñо¿×¨ÏîÈÎÎñÏîÄ¿£¬½ÌÓý²¿Éç»á¿ÆÑ§Ë¾¡¢Öйú¹¤³ÌÔº£¬2012Ä꣬ÏîÄ¿¸ºÔðÈË¡ªÕÅçñ¡£
£¨20£©àçÝÁÆÕ͡й¤ÒÕÑо¿£¬ºþ±±Ê¡½ÌÓýÌü¿Æ¼¼ÏîÄ¿£¬2008Ä꣬ÏîÄ¿¸ºÔðÈË¡ªÕÅçñ¡£
£¨21£©¹ú¼Ò¡°ÖØ´óÐÂÒ©´´ÖÆ¡±¿Æ¼¼ÖØ´óרÏî×ÓÏîÄ¿¡°¸ßЧҩÎïɸѡÑùÆ·¿âÖÆ±¸Æ½Ì¨½¨É衱£¬¾üÊÂҽѧ¿ÆÑ§Ôº¶¾ÎïÒ©ÎïÑо¿Ëù£¬2010Ä꣬ÏîÄ¿¸ºÔðÈË¡ªÕÅçñ¡£
£¨22£©ÔÁÏÒ©Éú²úÎ²ÆøµäÐÍ»ØÊÕ´¦Àí¹¤ÒÕ°üÑо¿Ó뿪·¢ÏîÄ¿£¬ÖйúÒ½Ò©¼¯ÍÅÎ人ҽҩÉè¼ÆÔº£¬2011Ä꣬ÏîÄ¿¸ºÔðÈË¡ªÕÅçñ¡£
£¨23£©SMZÔÓÖÊÓëTMPÔÓÖÊÑо¿ºÏ×÷ÐÒ飬Î÷ÄϺϳÉÖÆÒ©¹É·ÝÓÐÏÞ¹«Ë¾£¬2010Ä꣬ÏîÄ¿¸ºÔðÈË¡ªÕÅçñ¡£
£¨24£©×××µÄÑо¿£¬×Ü×°±¸²¿¡°Ê®¶þÎ塱¹æ»®±øÆ÷¿ÆÑ§Ô¤ÏÈÑо¿Ö§³ÅÏîÄ¿£¬2010Ä꣬ÏîÄ¿¸ºÔðÈË--ºúѧÀס£
£¨25£©ÐÂÐÍ˳²¬ÀàÒ©Îï-´ó»·²¬ÀàÅäºÏÎïµÄÉè¼Æ¡¢ºÏ³É¼°¿¹Ö×Áö»îÐÔÑо¿£¬ºþ±±Ê¡×ÔÈ»¿ÆÑ§»ù½ðÖØµãÏîÄ¿£¨2011CDA048£©£¬2011Ä꣬ÏîÄ¿¸ºÔðÈË--ºúѧÀס£
£¨26£©GABAÊÜÌ弤¶¯¼Á¡ª¡ªÓ¬Þ¦´¼£¨muscimol£©ÑÜÉúÎïµÄ·Ö×ÓÉè¼Æ¡¢ºÏ³É¼°¹¹Ð§¹ØÏµÑо¿£¬Ê¡½ÌÓýÌü¿ÆÑ§¼¼ÊõÑо¿¼Æ»®ÓÅÐãÖÐÇàÄêÈ˲ÅÏîÄ¿£¨Q20091505£©£¬2009Ä꣬ÏîÄ¿¸ºÔðÈË--·ë¾Õºì¡£
3. ´ú±íÐÔ¿ÆÑлñ½±
£¨1£©ÕÅçñ£¬2012Äê¶ÈÏíÊÜÊ¡Õþ¸®×¨Ïî½òÌù£¬ºþ±±Ê¡ÈËÁ¦×ÊÔ´ºÍÉç»á±£ÕÏÌü£¬2012Äê¶È¡£
£¨2£©×£ºê, ·Ç¹âÆø·¨Éú²úÍ×ÇúÖéÀûй¤ÒÕ¼°‡fàËᣨoxilinic acid£©ºÏ³Éй¤ÒÕ£¬ºþ±±Ê¡¿Æ¼¼½ø²½¶þµÈ½±£¬2008Äê¡£
£¨3£©×£ºê,Å£»ÇËṤÒÕÓÅ»¯¼°¹ý³Ì¿ØÖÆÑо¿£¬ºþ±±Ê¡¿Æ¼¼½ø²½ÈýµÈ½±£¬2008Äê¡£
£¨4£©×£ºê,Ë«ÂÈ·ÒËá¼ØÔÁϼ°Æ¬¼Á£¬ºþ±±Ê¡¿Æ¼¼½ø²½ÈýµÈ½±£¬2000Äê¡£
£¨5£©¾ÞÐÞÁ·£¬ÂȰ·Á׿ª·¢£¬´ó±±Å©¿Æ¼¼³É¹û½±£¬ÅÅÃûµÚ1, 2005Äê¡£
£¨6£©¾ÞÐÞÁ·£¬¿¹ÄæÐÔ²ÄÁÏ£¨RAD£©ÈóºÌ±¦µÄ¿ª·¢£¬É½Î÷Ê¡¿Æ¼¼½ø²½¶þµÈ½±£¬ÅÅÃûµÚ4, 2004Äê¡£
4. ÊÚȨרÀû
£¨1£©Íõ¿, ³Â´ï. 6-¼×Ñõ»ùßÕàº-3-ôÈËáµÄºÏ³É¹¤ÒÕ£¬·¢Ã÷רÀû£¬ZL 200910061172.9.
£¨2£©Íõ¿, ³Â´ï. 6-¼×Ñõ»ùßÕàº-3-ôÈËáµÄºÏ³É¹¤ÒÕ. ·¢Ã÷רÀû, ZL 200910061173.3.
£¨3£©Íõ¿, ³ØÈê°², ¹ù¼Î, ÕÅçñ, ·ûÕ×ÁÖ, ÕÅÐãÀ¼, »ÆæÃ. Ò»ÖÖÏÙàÑßʵÄÖÆ±¸·½·¨. ·¢Ã÷רÀû, ZL 201110004913.7,
£¨4£©Íõ¿, »ÆæÃ, ·ûÕ×ÁÖ. ¦Á-äå´úÈâ¹ðÈ©µÄÖÆ±¸¹¤ÒÕ. ·¢Ã÷רÀû, ZL201010251335.2.
£¨5£©Íõ¿, ³Â³¤Ì¶, Ò×°²Ã¯. Ò»ÖÖÖÆ±¸ÅÁÈðÎô²¼ÄƵķ½·¨. ·¢Ã÷רÀû, ZL 201110325186.4.
£¨6£©Íõ¿, Íõƽ. Ò»ÖÖÖÆ±¸2, 2-¶þÒì±û»ù±ûëæµÄ·½·¨. ·¢Ã÷רÀû, ZL201110037997.4.
£¨7£©Íõ¿, ½ðç÷, Ó÷·¢È«, ÕÅçñ, ³ØÈê°², »ÆæÃ, ÕÅÐãÀ¼, Íò´º½Ü. Ò»ÖÖ½¡ÄÇÂÌBµÄºÏ³É¹¤ÒÕ. ·¢Ã÷רÀû, ZL 201210047336.4.
(8) ¾ÞÐÞÁ·£¬ºÎÚ×£¬¹ùÉØÖÇ£¬Ö£Ö¾³¤£¬ËïÏÈÃ÷. ºË»ÆËØÁ×ËáÄÆµÄ¹¤Òµ»¯ÖƱ¸·½·¨.·¢Ã÷רÀû£¬ZL 201110085174.9£¬
(9) ¾ÞÐÞÁ·£¬Áõ¸ùÑ×£¬Â¬Â×. Ïõ»ùÑÇßäßòÍéÑÜÉúÎï¼°ÆäÖÆ±¸ºÍÓ¦ÓÃ, ·¢Ã÷רÀû£¬ZL 201010160247.1£¬
(10) ¾ÞÐÞÁ·£¬ÎâÓбó£¬ÖÜΡ. 4-Ìþ»ù-3-Çè»ùË«»·Áú×´Á×Ëáõ¥À༰ÆäÖÆ±¸ºÍÓ¦Ó㬷¢Ã÷רÀû£¬ZL 200810048438.1£¬
(11) ¾ÞÐÞÁ·£¬Â¬Â×£¬ÀîÀ裬ÀîË®Çå. 1-(2,3-»·Ñõ±û»ù)-N-Ïõ»ùÑÇßäßòÍé-2-»ù°·¼°ÆäÖÆ±¸·½·¨ºÍÓ¦Ó㬷¢Ã÷רÀû£¬ZL 200810236885.X£¬
£¨12£©×£ºê£¬ÅË־Ȩ£¬³ÂáÉ£¬ÌÆÖ¾ìÍ£¬ÈÙ¿·å. ½Ø¶Ì²à¶úËØµÄË®Ñîõ£°·ÃÑ»¯ºÏÎï¼°ÆäÖÆ±¸·½·¨. ·¢Ã÷רÀû£¬ZL 201110055029.6,
£¨13£©×£ºê£¬ãƸ£°²£¬ÅË־Ȩ. Íé»ùÝÁ»ÇËá²ôÔÓ¾Û±½°·µÄÖÆ±¸·½·¨. ·¢Ã÷רÀû£¬ZL 201010209756.9,
£¨14£©×£ºê£¬ÁõÓÀÇí£¬ÅËÊ¢¸Ö£¬¸ßϼ£¬ÀîʤËÉ£¬×ÞÓ¨.Áª±½ÒÒËáµÄÖÆ±¸·½·¨. ·¢Ã÷רÀû£¬ZL 200710052668.0,
£¨15£©ÀèÀò, ÇñÃô·¼, ´÷Á¢Õä. ÓÃÓÚÖÎÁÆÍ´·çµÄ»ÆàÑßÊÑõ»¯Ã¸ÒÖÖÆ¼Á¼°ÆäÖÆ±¸·½·¨. ·¢Ã÷רÀû£¬ZL2010.1 0028957.9,
£¨16£©ÀèÀò, Ñ. Ò»ÖÖÏû¶¾¿¹¾úÖгÉÒ©¼Á¼°ÆäÖÆ±¸·½·¨. ·¢Ã÷רÀû£¬ZL2010.1 0028957.9,
|